Towards the best kidney failure prediction tool: a systematic review and selection aid

Abstract

Background Prediction tools that identify chronic kidney disease (CKD) patients at a high risk of developing kidney failure have the potential for great clinical value, but limited uptake. The aim of the current study is to systematically review all available models predicting kidney failure in CKD patients, organize empirical evidence on their validity and ultimately provide guidance in the interpretation and uptake of these tools. Methods PubMed and EMBASE were searched for relevant articles. Titles, abstracts and full-text articles were sequentially screened for inclusion by two independent researchers. Data on study design, model development and performance were extracted. The risk of bias and clinical usefulness were assessed and combined in order to provide recommendations on which models to use. Results Of 2183 screened studies, a total of 42 studies were included in the current review. Most studies showed high discriminatory capacity and the included predictors had large overlap. Overall, the risk of bias was high. Slightly less than half the studies (48%) presented enough detail for the use of their prediction tool in practice and few models were externally validated. Conclusions The current systematic review may be used as a tool to select the most appropriate and robust prognostic model for various settings. Although some models showed great potential, many lacked clinical relevance due to being developed in a prevalent patient population with a wide range of disease severity. Future research efforts should focus on external validation and impact assessment in clinically relevant patient populations.

Validation of risk scores for ischaemic stroke in atrial fibrillation across the spectrum of kidney function

“…Given the increasing prevalence of CKD, and the frequent use of risk scores for IS in the care of patients with CKD, there is surprisingly little information on the predictive performance in this high-risk population. Except for GARFIELD-AF and ATRIA, none of the validated risk scores included patients with CKD in their development cohorts, or CKD-specific predictors 26 in their risk score. Furthermore, external validation—the cornerstone for assessment of predictive performance in ‘real-world’ patients—of these risk scores is essential, but seldom performed.…”

Organ donation and transplantation: a multi-stakeholder call to action

“…This Roadmap is complementary to those efforts and extends these initiatives by outlining a comprehensive multinational policy approach 33 , 35 , 36 . Barriers to transplantation 37 , 38 , which are often psychological and practical in nature, may be avoided through appropriate education and regulation 2 (Box 1 ).…”

Kidney Failure Prediction Models: A Comprehensive External Validation Study in Patients with Advanced CKD

“…A recent systematic review, conducted by our research group, identified prediction models for renal replacement therapy (RRT) initiation in CKD patients. 17 As the review included articles published up to December 31 st 2017, we updated the search to include articles published up to December 31 st 2018. For the current study we formulated a number of inclusion criteria.…”

“…SBP: systolic blood pressure, eGFR: estimated glomerular filtration rate, CVD: cardiovascular disease, uACR: urinary albumin creatinine ratio, s.: serum, 4v: 4 variable, 8v: 8 variable, USA: United States of America, UK: United Kingdom. * Data based on previously conducted systematic review of these studies 17. a sample size of external validation and recalibration meta-analysis, these recalibrated models are validated in the current study.…”